表紙
市場調查報告書
商品編碼
1040491

細胞、基因治療製造服務的全球市場(2021年∼2027年)

Global Cell and Gene Therapy Manufacturing Services Market 2021-2027

出版日期: | 出版商: Orion Market Research Pvt Ltd | 英文 | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球細胞、基因治療製造服務的市場規模,預計在預測期間內成長。帶動這個市場的主要原因,有癌症的發病率上升,及製藥企業的研究開發增加,製藥企業與開發、受託製造廠商(CDMO)之間的聯盟和協定等。

醫療保健產業是面臨嚴重中斷的主要產業之一,例如由於封鎖和辦公室關閉而導致的供應鏈中斷和製造中斷。然而,市場受到越來越多的基於細胞療法的臨床試驗的積極影響,這些試驗旨在治療COVID-19患者。

本報告提供全球細胞、基因治療製造服務市場調查,市場概要,市場的推動因素與阻礙因素分析,COVID-19的影響,市場機會,治療方法,規模,適應症,終端用戶,各地區的市場分析,主要企業的簡介等系統性資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

  • 調查範圍
  • 分析師的洞察和目前市場趨勢
  • 波特分析

第3章 競爭情形

  • 主要企業分析
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Lonza Group Ltd.
  • 重要的策略分析
  • COVID-19對主要企業的影響

第4章 市場決策要素

  • 促進因素
  • 阻礙因素
  • 市場機會

第5章 市場細分化

  • 細胞、基因治療製造服務的全球市場:各治療法
    • 細胞治療
    • 基因治療
  • 細胞、基因治療製造服務的全球市場:各規模
    • 商業化前/R&D規模製造
    • 商業規模的製造
  • 細胞、基因治療製造服務的全球市場:各適應症
    • 癌症
    • CVD
    • 整形外科
    • 感染疾病
    • 其他
  • 細胞、基因治療製造服務的全球市場:各終端用戶
    • 製藥及生物科技企業
    • 學術調查

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 其他地區

第7章 企業簡介

  • bluebird bio, Inc.
  • Boehringer Ingelheim International GmbH
  • Catalent, Inc.
  • Cell and Gene Therapy Catapult
  • Innovative Cellular Therapeutics Co., Ltd.
  • Charles River Laboratories International, Inc.
  • F. Hoffmann-La Roche Ltd.
  • FUJIFILM Holdings Corp.
  • Miltenyi Biotec B.V. & Co. KG
  • Nikon CeLL innovation Co., Ltd.
  • Novartis AG
  • Oxford Biomedica plc
  • Samsung Biologics
  • Takara Bio Inc.
  • WuXi AppTec Co., Ltd.
目錄
Product Code: OMR2024042

Global Cell and Gene Therapy Manufacturing Services Market Size, Share &Trends Analysis Report, By Therapy (Cell Therapy and Gene Therapy) By Scale (Pre-commercial/ R&D Scale Manufacturing, Commercial-Scale Manufacturing), By Indication (Cancer, CVD, Orthopedic, Infectious Diseases, and Others) By End-User (Pharmaceutical and Biotechnology Companies, and Academic and Research Institutes) Forecast Period, 2021-2027

The global cell and gene therapy manufacturing services market is projected to grow at a potential CAGR during the forecast period (2021-2027) The key aspect that drives the growth of the market includes the rising incidence of cancer coupled with the increasing R&D by pharmaceutical companies and partnerships &agreements between pharmaceutical companies and contract development and manufacturing organizations (CDMOs). Benefits of partnering with a cell or gene therapy CDMOs include scalability, speed to market, access to technical expertise without overhead costs, and cost-efficiency

Covid-19 has affected economies and industries in several countries due to lockdown, travel bans, and business shutdowns. The global healthcare industry is one of the major industries facing serious disruptions such as breaks in supply chains and disruptions in manufacturing due to lockdown and office shutdowns. However, an increased number of investigational studies based on cell therapies for the treatment of COVID-19 patients have led to a positive impact on the market

The global cell and gene therapy manufacturing services market is segmented based on therapy, scale, indication, and end-user. Based on therapy, the market is segmented into cell and gene therapy. Among, therapy, the cell therapy segment is expected to grow at a decent rate during the forecast period. The attributable factor for the growth of the segment is increasing awareness about cell therapy coupled with the development of genomics methods for cell analysis. Based on the scale, the market is segmented into pre-commercial/ R&D scale manufacturing, commercial-scale manufacturing. Among scale, pre-commercial/ R&D scale manufacturing holds a lucrative share in the market during the forecast period owing to the expansion of cell and gene pipelines across the globe

Based on end-user, the market is segmented into pharmaceutical and biotechnology companies and academic and research institutes. Among end-user, the pharmaceutical and biotechnology companies segment is expected to grow at a significant rate during the forecast period. The attributable factor for the growth of the segment is increasing R&D expenditure by the companies in the cell and gene therapies coupled with rising collaborations between pharmaceutical and biotechnology companies

The global cell and gene therapy manufacturing services market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. Asia-Pacific region is projected to hold a significant market share. China, India, Japan, and the Rest of the Asia-Pacific are the major economies primarily contributing to the growth of the cell and gene therapy manufacturing services market in the region. The regional growth of the market is accredited to the rising incidence of cancer in the economies such as China and India. North America held a major market position in the global cell and gene therapy manufacturing services market in 2020. The presence of key companies involved in the development of cell and gene therapy and growing investments in the field are some of the key factors driving the growth of the regional market. Europe is the second-largest market in 2020 owing to the presence of a strong workforce coupled with strong facilities

Further, Thermo Fisher Inc., Merck KGaA, and F. Hoffmann-La Roche Ltd., among others are some of the prominent players operating in the market. Strategic initiatives may support an increase in the market share of the players during the forecast period. The manufacturers are extensively investing in new technologies. Moreover, new launches &developments, partnerships and collaborations, and mergers and acquisitions are some of the growth strategies adopted by the players to sustain in the highly competitive market. For instance, in February 2020, Catalent Inc. announced the acquisition of MaSTherCell Global, Inc., for $315 million to expand its market presence in cell and gene therapy platforms

Research Methodology

The market study of the global cell and gene therapy manufacturing services market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to break down the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include

Financial reports of companies involved in the market

Whitepapers, research papers, and news blogs

Company websites and their product catalog

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

Global Cell and Gene Therapy Manufacturing Services Market Research and Analysis by Therapy

Global Cell and Gene Therapy Manufacturing Services Market Research and Analysis by Scale

Global Cell and Gene Therapy Manufacturing Services Market Research and Analysis by Indication

Global Cell and Gene Therapy Manufacturing Services Market Research and Analysis by End-User

The Report Covers

Comprehensive research methodology of the global cell and gene therapy manufacturing services market

This report also includes a detailed and extensive market overview with key analyst insights

An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations

Analysis of regional regulations and other government policies impacting the global cell and gene therapy manufacturing services market

Insights about market determinants that are stimulating the global cell and gene therapy manufacturing services market

Detailed and extensive market segments with regional distribution of forecast revenues

Extensive profiles and recent developments of the market player

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Cell and Gene Therapy Manufacturing Services Industry
  • Recovery Scenario of Global Cell and Gene Therapy Manufacturing Services Industry
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Conclusion
  • 2.3. Porter's Analysis

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Thermo Fisher Scientific Inc.
      • 3.1.1.1. Overview
      • 3.1.1.2. Financial Analysis
      • 3.1.1.3. SWOT Analysis
    • 3.1.2. Merck KGaA
      • 3.1.2.1. Overview
      • 3.1.2.2. Financial Analysis
      • 3.1.2.3. SWOT Analysis
    • 3.1.3. Lonza Group Ltd.
      • 3.1.3.1. Overview
      • 3.1.3.2. Financial Analysis
      • 3.1.3.3. SWOT Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Impact of COVID-19 on Key Players

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Cell and Gene Therapy Manufacturing Services Market by Therapy
    • 5.1.1. Cell Therapy
    • 5.1.2. Gene Therapy
  • 5.2. Global Cell and Gene Therapy Manufacturing Services Market by Scale
    • 5.2.1. Pre-commercial/ R&D Scale Manufacturing
    • 5.2.2. Commercial Scale Manufacturing
  • 5.3. Global Cell and Gene Therapy Manufacturing Services Market by Indication
    • 5.3.1. Cancer
    • 5.3.2. CVD
    • 5.3.3. Orthopedic
    • 5.3.4. Infectious Diseases
    • 5.3.5. Others
  • 5.4. Global Cell and Gene Therapy Manufacturing Services Market by End User
    • 5.4.1. Pharmaceutical and Biotechnology Companies
    • 5.4.2. Academic and Research Institutes

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. US
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. bluebird bio, Inc.
  • 7.2. Boehringer Ingelheim International GmbH
  • 7.3. Catalent, Inc.
  • 7.4. Cell and Gene Therapy Catapult
  • 7.5. Innovative Cellular Therapeutics Co., Ltd.
  • 7.6. Charles River Laboratories International, Inc.
  • 7.7. F. Hoffmann-La Roche Ltd.
  • 7.8. FUJIFILM Holdings Corp.
  • 7.9. Miltenyi Biotec B.V. & Co. KG
  • 7.10. Nikon CeLL innovation Co., Ltd.
  • 7.11. Novartis AG
  • 7.12. Oxford Biomedica plc
  • 7.13. Samsung Biologics
  • 7.14. Takara Bio Inc.
  • 7.15. WuXi AppTec Co., Ltd.

LIST OF TABLES

  • 1. GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS BY THERAPY, 2020-2027 ($ MILLION)
  • 2. GLOBAL CELL THERAPY MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL GENE THERAPY MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS BY SCALE, 2020-2027 ($ MILLION)
  • 5. GLOBAL PRECOMMERCIAL/ R&D SCALE CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL COMMERCIAL-SCALE CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 7. GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS BY INDICATION, 2020-2027 ($ MILLION)
  • 8. GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES FOR CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 9. GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES FOR CVD MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 10. GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES FOR ORTHOPEDIC MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 11. GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES FOR INFECTIOUS DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 12. GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES FOR OTHER INDICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 13. GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 14. GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 15. GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES FOR ACADEMIC AND RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 16. GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
  • 17. NORTH AMERICAN CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 18. NORTH AMERICAN CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS BY THERAPY, 2020-2027 ($ MILLION)
  • 19. NORTH AMERICAN CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS BY SCALE, 2020-2027 ($ MILLION)
  • 20. NORTH AMERICAN CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS BY INDICATION, 2020-2027 ($ MILLION)
  • 21. NORTH AMERICAN CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 22. EUROPEAN CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 23. EUROPEAN CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS BY THERAPY, 2020-2027 ($ MILLION)
  • 24. EUROPEAN CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS BY SCALE, 2020-2027 ($ MILLION)
  • 25. EUROPEAN CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS BY INDICATION, 2020-2027 ($ MILLION)
  • 26. EUROPEAN CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 27. ASIA-PACIFIC CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 28. ASIA-PACIFIC CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS BY THERAPY, 2020-2027 ($ MILLION)
  • 29. ASIA-PACIFIC CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS BY SCALE, 2020-2027 ($ MILLION)
  • 30. ASIA-PACIFIC CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS BY INDICATION, 2020-2027 ($ MILLION)
  • 31. ASIA-PACIFIC CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 32. REST OF THE WORLD CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS BY THERAPY, 2020-2027 ($ MILLION)
  • 33. REST OF THE WORLD CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS BY SCALE, 2020-2027 ($ MILLION)
  • 34. REST OF THE WORLD CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS BY INDICATION, 2020-2027 ($ MILLION)
  • 35. REST OF THE WORLD CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET, 2020-2027 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET BY SEGMENT, 2020-2027 ($ MILLION)
  • 3. RECOVERY OF GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET, 2021-2027(%)
  • 4. GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SHARE BY THERAPY, 2020 VS 2027 (%)
  • 5. GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SHARE BY SCALE, 2020 VS 2027 (%)
  • 6. GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SHARE BY INDICATION, 2020 VS 2027 (%)
  • 7. GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SHARE BY END-USER, 2020 VS 2027 (%)
  • 8. GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 9. GLOBAL CELL THERAPY MANUFACTURING SERVICES MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 10. GLOBAL GENE THERAPY MANUFACTURING SERVICES MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 11. GLOBAL PRE-COMMERCIAL/ R&D SCALE MANUFACTURING CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 12. GLOBAL COMMERCIAL-SCALE MANUFACTURING CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 13. GLOBAL CELL PROCESSING MANUFACTURING SERVICES MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 14. GLOBAL CELL BANKING CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 15. GLOBAL PROCESS DEVELOPMENT IN CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 16. GLOBAL VECTOR PRODUCTION IN CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 17. GLOBAL OTHERS (RAW MATERIAL TESTING) CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 18. GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 19. GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES FOR ACADEMIC AND RESEARCH INSTITUTES MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 20. US CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 21. CANADA CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 22. UK CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 23. FRANCE CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 24. GERMANY CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 25. ITALY CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 26. SPAIN CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 27. ROE CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 28. INDIA CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 29. CHINA CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 30. JAPAN CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 31. ASEAN CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 32. SOUTH KOREA CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 33. REST OF ASIA-PACIFIC CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2020-2027 ($ MILLION)
  • 34. REST OF THE WORLD CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SIZE, 2020-2027 ($ MILLION)